Kiniksa Pharmaceuticals International Plc (KNSA)
41.16
-0.39
(-0.94%)
USD |
NASDAQ |
Dec 09, 16:00
41.16
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Market Cap: 3.120B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CorMedix, Inc. | 914.74M |
| NovoCure Ltd. | 1.423B |
| LivaNova Plc | 3.387B |
| ADMA Biologics, Inc. | 4.712B |
| ACADIA Pharmaceuticals, Inc. | 4.549B |
Market Cap Related Metrics
| PE Ratio | 91.81 |
| PS Ratio | 5.273 |
| Price to Book Value | 5.827 |
| Price to Free Cash Flow | 31.00 |
| Price | 41.16 |
| Earnings Yield | 1.09% |
| Operating PE Ratio | 82.65 |
| Normalized PE Ratio | 91.81 |